NasdaqGS - Nasdaq Real Time Price USD

Cellebrite DI Ltd. (CLBT)

11.48 +0.01 (+0.04%)
As of 11:07 AM EDT. Market Open.
Loading Chart for CLBT
DELL
  • Previous Close 11.47
  • Open 11.57
  • Bid 11.45 x 100
  • Ask 11.48 x 200
  • Day's Range 11.37 - 11.61
  • 52 Week Range 5.22 - 12.50
  • Volume 197,173
  • Avg. Volume 913,091
  • Market Cap (intraday) 2.356B
  • Beta (5Y Monthly) 1.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.43
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 13.58

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

www.cellebrite.com

1,008

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLBT

Performance Overview: CLBT

Trailing total returns as of 5/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLBT
32.51%
S&P 500
11.62%

1-Year Return

CLBT
108.26%
S&P 500
28.71%

3-Year Return

CLBT
16.38%
S&P 500
27.55%

5-Year Return

CLBT
--
S&P 500
51.70%

Compare To: CLBT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLBT

Valuation Measures

Annual
As of 5/15/2024
  • Market Cap

    2.35B

  • Enterprise Value

    2.07B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.71

  • Price/Book (mrq)

    68.83

  • Enterprise Value/Revenue

    6.35

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.03%

  • Return on Assets (ttm)

    4.47%

  • Return on Equity (ttm)

    -150.08%

  • Revenue (ttm)

    311.55M

  • Net Income Avi to Common (ttm)

    -81.1M

  • Diluted EPS (ttm)

    -0.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    302.92M

  • Total Debt/Equity (mrq)

    41.30%

  • Levered Free Cash Flow (ttm)

    81.72M

Research Analysis: CLBT

Company Insights: CLBT

Research Reports: CLBT

People Also Watch